Free priority shipping over $200 · Same-day dispatch from Miami, FL

Alphapep

RESEARCH USE ONLY. All Alphapep compounds are for in-vitro laboratory research. Not for human or veterinary use, diagnosis, or consumption.

Secretagogue Research

GHRH analog reference material

Tesamorelin supplied as lyophilized reference material for in-vitro receptor work. Laboratory research use only.

Compounds
1
Purity
99.89%
Certificates
1
Method
LCMS-UV

1 compound in this line

Scope

What the molecule is

Tesamorelin is a synthetic analog of growth-hormone-releasing hormone: a peptide of forty-four amino acids carrying an N-terminal modification that distinguishes it from the native sequence. It is supplied as a characterised reference standard for in-vitro work on GHRH receptor pharmacology, and Alphapep offers it for no other purpose.

Tesamorelin
GHRH Analog — 44 amino acids
Formula
C221H366N72O67S
Mass
5,135.8 Da
Supplied as
10mg
Fig. 1 — What is supplied in this line, by composition.
Documentation

Analytical specification

Each lot is assayed by an independent laboratory by LCMS-UV, which reports purity as UV peak-area percentage and confirms identity by mass. Those are separate results: a sample can be highly pure and still be the wrong molecule, which is why both appear on the certificate. The certificate is issued against the lot in the vial.

01
Lot synthesised
02
Independent lab · LCMS-UV
03
Certificate per lot
Purity
99.89%
Identity
Mass match
Classification

The family, as the databases record it

The compound in this line belongs to a family that InterPro and UniProt recognise: the growth-hormone-releasing-hormone analogues, separated at sub-entry level within the wider glucagon-secretin superfamily. The peptide portion reproduces the 44-residue mature sequence carried inside the 108-residue precursor recorded under UniProt P01286.

Superfamily
Glucagon-secretin peptide superfamily
Sub-entry
Growth-hormone-releasing-hormone analogues
Supplied in this line
Secretagogue Research
Tesamorelin
Fig. 3 — Where the line sits in the classification databases.
Structure

What separates the catalogued compound from the native sequence

Two synthetic modifications, and both are compositional rather than incidental. The alpha-amine of the first residue is acylated with a trans-3-hexenoyl group, an unsaturated six-carbon unit contributing C6H8O, and the C-terminus is presented as an amide rather than a free acid. Building the formula from the native chain and applying both modifications reproduces the deposited composition exactly, which confirms the substitution pattern independently of the sequence assignment.

Compounds
1
Assay method
LCMS-UV
Laboratory
ACS Peptide Testing Labs
Certificate date
2026-07-28
Appearance
White powder
Fig. 4 — The line as the catalogue records it.
Measurement

The boundary against its neighbours

Length and that acyl group draw it. The 29-residue N-terminal analogues of the same hormone family are separated by more than 1700 Da in mass and carry no acyl substituent at all, so the two are never in question by mass spectrometry.

Reported as
99.89%

Percentage of total UV peak area attributable to the target compound.

Confirmed by
Mass match

Measured mass of the principal peak against the calculated mass for the sequence.

Tied to
AAHW064

Each certificate is issued against a specific accession, not against the compound.

Fig. 5 — What the measurement rests on.

Certificates of analysis

All certificates